Pomanda estimates the enterprise value of ELASMOGEN LIMITED at £2.6m based on a Turnover of £1.9m and 1.37x industry multiple (adjusted for size and gross margin).
elasmogen limitedEstimated Valuation
£0
Pomanda estimates the enterprise value of ELASMOGEN LIMITED at £0 based on an EBITDA of £-2.4m and a 5.38x industry multiple (adjusted for size and gross margin).
elasmogen limitedEstimated Valuation
£8m
Pomanda estimates the enterprise value of ELASMOGEN LIMITED at £8m based on Net Assets of £4.5m and 1.79x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Elasmogen LimitedOverview
Elasmogen Limited is a live company located in aberdeen, AB25 2ZP with a Companies House number of SC467513. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in January 2014, it's largest shareholder is
kcp nominees ltd
with a 20.4% stake. Elasmogen Limited is a established,
small sized company, Pomanda has estimated its turnover at
£1.9m with
rapid
growth in recent years.
Pomanda's financial health check has awarded Elasmogen Limited a 4 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 4 areas for improvement. Company Health Check FAQs
Health Rating4out of 5
4 Strong
2 Regular
4 Weak
Size
annual sales of £1.9m, make it smaller than the average company (£4.1m)
£1.9m - Elasmogen Limited
£4.1m - Industry AVG
Growth
3 year (CAGR) sales growth of 42%, show it is growing at a faster rate (12.3%)
42% - Elasmogen Limited
12.3% - Industry AVG
Production
with a gross margin of 54.2%, this company has a comparable cost of product (54.2%)
54.2% - Elasmogen Limited
54.2% - Industry AVG
Profitability
an operating margin of -131.9% make it less profitable than the average company (-7%)
-131.9% - Elasmogen Limited
-7% - Industry AVG
Employees
with 18 employees, this is below the industry average (49)
18 - Elasmogen Limited
49 - Industry AVG
Pay Structure
on an average salary of £82.4k, the company has an equivalent pay structure (£82.4k)
£82.4k - Elasmogen Limited
£82.4k - Industry AVG
Efficiency
resulting in sales per employee of £104.6k, this is less efficient (£127.9k)
£104.6k - Elasmogen Limited
£127.9k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Elasmogen Limited
- - Industry AVG
Creditor Days
its suppliers are paid after 133 days, this is slower than average (52 days)
133 days - Elasmogen Limited
52 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Elasmogen Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities
for 431 weeks, this is more cash available to meet short term requirements (30 weeks)
431 weeks - Elasmogen Limited
30 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 9.8%, this is a lower level of debt than the average (52.2%)
9.8% - Elasmogen Limited
52.2% - Industry AVG
ELASMOGEN LIMITED financials
EXPORT
Elasmogen Limited's latest turnover from January 2024 is estimated at £1.9 million and the company has net assets of £4.5 million. According to their latest financial statements, Elasmogen Limited has 18 employees and maintains cash reserves of £4 million as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Jan 2024
Jan 2023
Jan 2022
Jan 2021
Jan 2020
Jan 2019
Jan 2018
Jan 2017
Jan 2016
Jan 2015
Turnover
1,882,781
790,129
922,201
653,938
678,215
606,903
278,530
186,221
295,173
Other Income Or Grants
Cost Of Sales
863,194
376,034
473,330
304,406
332,908
279,677
131,402
96,678
164,577
Gross Profit
1,019,587
414,095
448,871
349,532
345,307
327,227
147,128
89,543
130,596
Admin Expenses
3,502,617
2,071,906
1,805,333
1,015,436
825,005
881,627
501,103
401,686
163,476
Operating Profit
-2,483,030
-1,657,811
-1,356,462
-665,904
-479,698
-554,400
-353,975
-312,143
-32,880
Interest Payable
1,630
12,285
15,331
7,592
26,156
52,312
39,812
14,063
Interest Receivable
269,405
123,532
2,052
585
2,112
2,033
1,151
214
3
Pre-Tax Profit
-2,215,255
-1,546,564
-1,369,740
-672,911
-503,742
-604,680
-392,637
-325,991
-32,877
Tax
Profit After Tax
-2,215,255
-1,546,564
-1,369,740
-672,911
-503,742
-604,680
-392,637
-325,991
-32,877
Dividends Paid
Retained Profit
-2,215,255
-1,546,564
-1,369,740
-672,911
-503,742
-604,680
-392,637
-325,991
-32,877
Employee Costs
1,483,633
827,860
551,300
487,657
541,702
543,314
311,325
233,063
161,802
Number Of Employees
18
11
7
7
8
8
5
4
3
EBITDA*
-2,399,294
-1,608,308
-1,317,562
-624,892
-446,284
-534,467
-344,966
-311,760
-32,880
* Earnings Before Interest, Tax, Depreciation and Amortisation
Jan 2024
Jan 2023
Jan 2022
Jan 2021
Jan 2020
Jan 2019
Jan 2018
Jan 2017
Jan 2016
Jan 2015
Tangible Assets
193,869
228,013
40,744
32,155
20,688
35,899
953
840
Intangible Assets
241,455
260,857
280,259
300,460
218,439
165,739
102,290
104,943
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
435,324
488,870
321,003
332,615
239,127
201,638
103,243
105,783
Stock & work in progress
Trade Debtors
891
725
3,018
2,006
Group Debtors
Misc Debtors
552,583
523,550
489,019
265,842
99,941
259,875
257,565
27,737
94,153
Cash
3,987,800
6,275,249
783,709
858,055
311,316
251,922
290,116
170,095
1,299
misc current assets
total current assets
4,540,383
6,799,690
1,273,453
1,123,897
411,257
511,797
550,699
199,838
95,452
total assets
4,975,707
7,288,560
1,594,456
1,456,512
650,384
713,435
653,942
305,621
95,452
Bank overdraft
Bank loan
5,000
5,000
5,000
3,750
Trade Creditors
315,604
342,474
838,940
132,543
31,543
19,524
29,133
19,654
94,154
Group/Directors Accounts
other short term finances
220,000
149,995
149,995
hp & lease commitments
other current liabilities
159,748
185,474
64,288
43,252
40,629
99,157
33,367
160,934
34,169
total current liabilities
480,352
532,948
1,128,228
179,545
72,172
268,676
212,495
180,588
128,323
loans
7,017
11,960
16,667
245,161
625,000
625,000
450,000
hp & lease commitments
Accruals and Deferred Income
other liabilities
40,059
29,542
29,542
29,542
175,940
122,494
33,891
provisions
total long term liabilities
7,017
52,019
46,209
274,703
29,542
800,940
747,494
483,891
total liabilities
487,369
584,967
1,174,437
454,248
101,714
1,069,616
959,989
664,479
128,323
net assets
4,488,338
6,703,593
420,019
1,002,264
548,670
-356,181
-306,047
-358,858
-32,871
total shareholders funds
4,488,338
6,703,593
420,019
1,002,264
548,670
-356,181
-306,047
-358,858
-32,871
Jan 2024
Jan 2023
Jan 2022
Jan 2021
Jan 2020
Jan 2019
Jan 2018
Jan 2017
Jan 2016
Jan 2015
Operating Activities
Operating Profit
-2,483,030
-1,657,811
-1,356,462
-665,904
-479,698
-554,400
-353,975
-312,143
-32,880
Depreciation
64,334
30,101
16,540
18,778
16,917
7,522
391
383
Amortisation
19,402
19,402
22,360
22,234
16,497
12,411
8,618
Tax
Stock
Debtors
28,142
34,697
223,902
165,901
-159,934
-708
230,840
-64,410
94,153
Creditors
-26,870
-496,466
706,397
101,000
12,019
-9,609
9,479
-74,500
94,154
Accruals and Deferred Income
-25,726
121,186
21,036
2,623
-58,528
65,790
-127,567
126,765
34,169
Deferred Taxes & Provisions
Cash flow from operations
-2,480,032
-2,018,285
-814,031
-687,170
-332,859
-477,578
-693,894
-195,085
1,290
Investing Activities
capital expenditure
-30,190
-217,370
-27,288
-134,500
-70,903
-118,328
-6,469
-106,166
Change in Investments
cash flow from investments
-30,190
-217,370
-27,288
-134,500
-70,903
-118,328
-6,469
-106,166
Financing Activities
Bank loans
1,250
3,750
Group/Directors Accounts
Other Short Term Loans
-220,000
220,000
-149,995
149,995
Long term loans
-4,943
-4,707
-228,494
245,161
-625,000
175,000
450,000
Hire Purchase and Lease Commitments
other long term liabilities
-40,059
10,517
-146,398
53,446
88,603
33,891
share issue
7,830,138
787,495
1,126,505
1,408,593
554,546
445,448
4
6
interest
267,775
111,247
-13,279
-7,007
-24,044
-50,279
-38,661
-13,849
3
cash flow from financing
222,773
7,727,195
766,972
1,368,409
463,156
557,713
820,385
470,046
9
cash and cash equivalents
cash
-2,287,449
5,491,540
-74,346
546,739
59,394
-38,194
120,021
168,796
1,299
overdraft
change in cash
-2,287,449
5,491,540
-74,346
546,739
59,394
-38,194
120,021
168,796
1,299
elasmogen limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for elasmogen limited. Get real-time insights into elasmogen limited's credit score, group structure and payment trends.
Perform a competitor analysis for elasmogen limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other small companies, companies in AB25 area or any other competitors across 12 key performance metrics.
elasmogen limited Ownership
ELASMOGEN LIMITED group structure
Elasmogen Limited has no subsidiary companies.
Ultimate parent company
ELASMOGEN LIMITED
SC467513
ELASMOGEN LIMITED Shareholders
The largest shareholders in Elasmogen Limited include Kcp Nominees Ltd and Scottish Investments Limited.
kcp nominees ltd
20.38%
scottish investments limited
15.69%
bgf nominees limited (a/c bgf investments lp)
15.69%
scottish enterprise
13.43%
university court of the university of aberdeen
12.52%
caroline jane barelle
9.64%
andrew justin radcliffe porter
5.92%
john steven
1.69%
the university of maryland
1.69%
marina kovaleva
1.69%
elasmogen limited directors
Elasmogen Limited currently has 6 directors.
The longest serving directors include
Prof Caroline Barelle (Sep 2015) and
Professor Andrew Porter (Nov 2015).
72110 - Research and experimental development on biotechnology
incorporation date
January 2014
age
11
incorporated
UK
ultimate parent company
None
accounts
Full Accounts
last accounts submitted
January 2024
previous names
pacific shelf 1760 limited (February 2014)
accountant
A J B SCHOLES LTD
auditor
-
address
liberty building, foresterhill, aberdeen, AB25 2ZP
Bank
-
Legal Advisor
-
elasmogen limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to elasmogen limited.
elasmogen limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ELASMOGEN LIMITED. This can take several minutes, an email will notify you when this has completed.
elasmogen limitedCompanies House Filings - See Documents
